Rheumatology

Back to articles

Etanercept Effective in Patients with Psoriasis, Psoriatic Arthritis

KEY POINT

The tumor necrosis factor (TNF) inhibitor etanercept (Enbrel—Immunex, Wyeth-Ayerst) is proving a useful addition to available systemic therapies for psoriasis and psoriatic arthritis.

SOURCES

Mease PJ et al. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet. 2000;356:385–90.